Related Experiment Videos
Neuroblastoma: report on a 21-year experience
Journal of Pediatric Surgery
|May 1, 1986
Summary
Neuroblastoma prognosis is significantly influenced by patient age, tumor site, and cellular differentiation. Younger patients and those with tumors in the cervical, thoracic, or pelvic regions show better survival rates.
Area of Science:
- Pediatric Oncology
- Surgical Oncology
Background:
- Neuroblastoma is a common pediatric malignancy originating from neural crest cells.
- Management and prognostic factors for neuroblastoma require continuous evaluation.
Purpose of the Study:
- To review neuroblastoma cases managed at a single institution over a 20-year period.
- To identify key prognostic indicators for neuroblastoma survival.
Main Methods:
- Retrospective review of 80 neuroblastoma patients diagnosed between 1963 and 1983.
- Analysis of patient demographics, tumor characteristics, treatment modalities, and survival data.
Main Results:
- The 2- and 5-year survival rates were 36% and 25%, respectively.
- Independent prognostic factors included age at diagnosis, tumor site (cervical, thoracic, pelvic better than abdominal), and cellular differentiation.
- Infants with stage IV-S neuroblastoma had a poor prognosis; urinary VMA and calcifications were not predictive.
Conclusions:
- Age, tumor site, and differentiation are critical for predicting neuroblastoma outcomes.
- Early diagnosis and appropriate management based on these factors are essential for improving survival rates in pediatric neuroblastoma.